

소개
Persistent infection with high-risk human papillomavirus is associated with virtually all cervical cancers and a significant proportion of anogenital and oropharyngeal cancers. In recent years, significant progress has been made in cervical cancer prevention, especially in terms of the availability of prophylactic vaccines. However, the HPV vaccine has not yet achieved full coverage, and rates have dropped during the COVID-19 pandemic.



